BOIRON SA (BOI.PA) Stock Fundamental Analysis

EPA:BOI • FR0000061129

29.85 EUR
+0.35 (+1.19%)
Last: Feb 13, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, BOI scores 4 out of 10 in our fundamental rating. BOI was compared to 52 industry peers in the Pharmaceuticals industry. While BOI has a great health rating, there are worries on its profitability. BOI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year BOI was profitable.
  • BOI had a positive operating cash flow in the past year.
  • In the past 5 years BOI has always been profitable.
  • In the past 5 years BOI always reported a positive cash flow from operatings.
BOI.PA Yearly Net Income VS EBIT VS OCF VS FCFBOI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • The Return On Assets of BOI (3.45%) is worse than 63.64% of its industry peers.
  • BOI has a worse Return On Equity (5.25%) than 61.82% of its industry peers.
  • The Return On Invested Capital of BOI (4.43%) is worse than 61.82% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BOI is significantly below the industry average of 14.38%.
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROIC 4.43%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
BOI.PA Yearly ROA, ROE, ROICBOI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.84%, BOI is doing worse than 61.82% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BOI has declined.
  • BOI has a worse Operating Margin (5.26%) than 63.64% of its industry peers.
  • BOI's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 73.71%, BOI is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
  • BOI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
BOI.PA Yearly Profit, Operating, Gross MarginsBOI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

  • BOI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BOI has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BOI has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BOI has a worse debt to assets ratio.
BOI.PA Yearly Shares OutstandingBOI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BOI.PA Yearly Total Debt VS Total AssetsBOI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BOI has an Altman-Z score of 3.76. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of BOI (3.76) is comparable to the rest of the industry.
  • BOI has a debt to FCF ratio of 0.49. This is a very positive value and a sign of high solvency as it would only need 0.49 years to pay back of all of its debts.
  • BOI's Debt to FCF ratio of 0.49 is amongst the best of the industry. BOI outperforms 92.73% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that BOI is not too dependend on debt financing.
  • BOI's Debt to Equity ratio of 0.04 is amongst the best of the industry. BOI outperforms 89.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Altman-Z 3.76
ROIC/WACC0.54
WACC8.13%
BOI.PA Yearly LT Debt VS Equity VS FCFBOI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • BOI has a Current Ratio of 2.39. This indicates that BOI is financially healthy and has no problem in meeting its short term obligations.
  • BOI has a better Current ratio (2.39) than 78.18% of its industry peers.
  • BOI has a Quick Ratio of 1.46. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BOI (1.46) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.46
BOI.PA Yearly Current Assets VS Current LiabilitesBOI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • BOI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.09%.
  • Measured over the past years, BOI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.40% on average per year.
  • The Revenue has been growing slightly by 4.80% in the past year.
  • Measured over the past years, BOI shows a decrease in Revenue. The Revenue has been decreasing by -2.63% on average per year.
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.73% on average over the next years.
  • BOI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.54% yearly.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BOI.PA Yearly Revenue VS EstimatesBOI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BOI.PA Yearly EPS VS EstimatesBOI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 26.65, the valuation of BOI can be described as expensive.
  • 60.00% of the companies in the same industry are cheaper than BOI, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.68. BOI is around the same levels.
  • Based on the Price/Forward Earnings ratio of 12.91, the valuation of BOI can be described as correct.
  • BOI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BOI is cheaper than 80.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BOI to the average of the S&P500 Index (28.06), we can say BOI is valued rather cheaply.
Industry RankSector Rank
PE 26.65
Fwd PE 12.91
BOI.PA Price Earnings VS Forward Price EarningsBOI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • BOI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BOI is cheaper than 94.55% of the companies in the same industry.
  • 83.64% of the companies in the same industry are more expensive than BOI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.05
EV/EBITDA 6.54
BOI.PA Per share dataBOI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BOI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.82
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

  • BOI has a Yearly Dividend Yield of 4.07%, which is a nice return.
  • BOI's Dividend Yield is rather good when compared to the industry average which is at 1.89. BOI pays more dividend than 83.64% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, BOI pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.07%

5.2 History

  • The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
BOI.PA Yearly Dividends per shareBOI.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

  • BOI pays out 107.57% of its income as dividend. This is not a sustainable payout ratio.
DP107.57%
EPS Next 2Y2.73%
EPS Next 3YN/A
BOI.PA Yearly Income VS Free CF VS DividendBOI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BOI.PA Dividend Payout.BOI.PA Dividend Payout, showing the Payout Ratio.BOI.PA Dividend Payout.PayoutRetained Earnings

BOIRON SA

EPA:BOI (2/13/2026, 7:00:00 PM)

29.85

+0.35 (+1.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)04-02
Inst Owners5.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap523.87M
Revenue(TTM)504.86M
Net Income(TTM)19.37M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.07%
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP107.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 26.65
Fwd PE 12.91
P/S 1.04
P/FCF 14.05
P/OCF 9.9
P/B 1.42
P/tB 2.1
EV/EBITDA 6.54
EPS(TTM)1.12
EY3.75%
EPS(NY)2.31
Fwd EY7.75%
FCF(TTM)2.12
FCFY7.12%
OCF(TTM)3.02
OCFY10.1%
SpS28.77
BVpS21.03
TBVpS14.24
PEG (NY)4.82
PEG (5Y)N/A
Graham Number23.02
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROCE 5.9%
ROIC 4.43%
ROICexc 5.25%
ROICexgc 7.65%
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
FCFM 7.39%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexgc growth 3Y-33.41%
ROICexgc growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Debt/EBITDA 0.2
Cap/Depr 35.13%
Cap/Sales 3.1%
Interest Coverage 30.02
Cash Conversion 74.49%
Profit Quality 192.52%
Current Ratio 2.39
Quick Ratio 1.46
Altman-Z 3.76
F-Score7
WACC8.13%
ROIC/WACC0.54
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-11.18%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.74%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y57.85%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%

BOIRON SA / BOI.PA FAQ

Can you provide the ChartMill fundamental rating for BOIRON SA?

ChartMill assigns a fundamental rating of 4 / 10 to BOI.PA.


What is the valuation status of BOIRON SA (BOI.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BOIRON SA (BOI.PA). This can be considered as Fairly Valued.


How profitable is BOIRON SA (BOI.PA) stock?

BOIRON SA (BOI.PA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for BOI stock?

The Price/Earnings (PE) ratio for BOIRON SA (BOI.PA) is 26.65 and the Price/Book (PB) ratio is 1.42.


Is the dividend of BOIRON SA sustainable?

The dividend rating of BOIRON SA (BOI.PA) is 5 / 10 and the dividend payout ratio is 107.57%.